High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis

<table>Changes in the Life Quality Index (LQI) over time after IgSC initiation. The Life Quality Index (LQI) was used to assess the treatment satisfaction. This scale comprises 18 items ranging from 1 to 7. The sum of scores is then adjusted to obtain a total score of 100 points. Improvement in LQI was observed starting from two months after the initiation of SCIg and reaching the maximum values after five months.</table>

Case Reports in Rheumatology

fig2

Figure 2

Figure 2: High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis 